News Releases

Date	Title	Document
Date Aug 10, 2022	Title Oncocyte Reports Second Quarter 2022 Financial Results	Document PDF
Date Aug 03, 2022	Title Oncocyte to Participate at Upcoming Investor Conferences	Document PDF
Date Aug 01, 2022	Title Oncocyte Announces the Appointment of John Peter Gutfreund as Independent Member of Its Board of Directors Effective July 28, 2022	Document PDF
Date Jul 27, 2022	Title Oncocyte to Announce Second Quarter 2022 Financial Results	Document PDF
Date Jul 13, 2022	Title Oncocyte Announces Market Entry and Early Adopter Program for Transplant Rejection Monitoring Business	Document PDF
Date Jul 06, 2022	Title Oncocyte Presents DetermaIO™ Data in Podium Presentation at ESMO World Congress on Gastrointestinal Cancer 2022	Document PDF
Date Jun 22, 2022	Title Oncocyte Hosting Key Opinion Webinar on the Role of DetermaIO and the Tumor Microenvironment in Clinical Practice	Document PDF
Date May 26, 2022	Title Oncocyte Presents DetermaIO™ Data at ASCO 2022 Supporting the Test’s Potential to Expand the Clinical Use of Immunotherapy	Document PDF
Date May 11, 2022	Title Oncocyte Reports First Quarter 2022 Financial Results	Document PDF
Date May 05, 2022	Title Oncocyte Completes Validation of TheraSure™ Transplant Monitor Test	Document PDF